Skip to main content

Age-dependent human β cell proliferation induced by glucagon-like peptide 1 and calcineurin signaling.

Citation
Dai, Chunhua, et al. “Age-Dependent Human β Cell Proliferation Induced by Glucagon-Like Peptide 1 and Calcineurin Signaling”. 2017. The Journal of Clinical Investigation, vol. 127, no. 10, 2017, pp. 3835–3844.
Center Vanderbilt University
Author Chunhua Dai, Yan Hang, Alena Shostak, Greg Poffenberger, Nathaniel Hart, Nripesh Prasad, Neil Phillips, Shawn E Levy, Dale L Greiner, Leonard D Shultz, Rita Bottino, Seung K Kim, Alvin C Powers
Abstract

Inadequate pancreatic β cell function underlies type 1 and type 2 diabetes mellitus. Strategies to expand functional cells have focused on discovering and controlling mechanisms that limit the proliferation of human β cells. Here, we developed an engraftment strategy to examine age-associated human islet cell replication competence and reveal mechanisms underlying age-dependent decline of β cell proliferation in human islets. We found that exendin-4 (Ex-4), an agonist of the glucagon-like peptide 1 receptor (GLP-1R), stimulates human β cell proliferation in juvenile but not adult islets. This age-dependent responsiveness does not reflect loss of GLP-1R signaling in adult islets, since Ex-4 treatment stimulated insulin secretion by both juvenile and adult human β cells. We show that the mitogenic effect of Ex-4 requires calcineurin/nuclear factor of activated T cells (NFAT) signaling. In juvenile islets, Ex-4 induced expression of calcineurin/NFAT signaling components as well as target genes for proliferation-promoting factors, including NFATC1, FOXM1, and CCNA1. By contrast, expression of these factors in adult islet β cells was not affected by Ex-4 exposure. These studies reveal age-dependent signaling mechanisms regulating human β cell proliferation, and identify elements that could be adapted for therapeutic expansion of human β cells.

Year of Publication
2017
Journal
The Journal of clinical investigation
Volume
127
Issue
10
Number of Pages
3835-3844
Date Published
10/2017
ISSN Number
1558-8238
DOI
10.1172/JCI91761
Alternate Journal
J. Clin. Invest.
PMID
28920919
PMCID
PMC5617654
Download citation